This has opened the door for interest in the health sector about the vaccines that could reduce, if not eliminate, child deaths in the Philippines.
Data from various online sources showed that the three strains are present in nearly 20 percent of samples taken from Filipino children with pneumonia in the past. A memo of the bidding suspension issued by the DOH said the pause in bidding would give a chance for a review of “technical specifications” of PCV-13 although the Philippine public health sector had been familiar with the vaccine since 2014.
According to the US website Medline Plus, PCV 13 is “routinely given to children at 2, 4, 6 and 12-15 months of age.” Philippine Health Secretary Francisco Duque III, in a report shortly after the suspension of PCV 13 supply bidding was announced, said the study for the vaccine has been referred to the HTAC as a matter of procedure and in line with the 2018 law on universal health care.
From 2015 to 2019, the reports added, at least 18 countries introduced PCV-13 into their immunization programs. “The bidding is on hold until the review is completed,” Domingo was quoted as saying by multiple reports. Assistant Health Secretary Maria Vergeire was cited in different reports as saying PCV-10 was “still undergoing health technology assessment.”
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: manilabulletin - 🏆 25. / 51 Read more »
Source: CNN Philippines - 🏆 13. / 63 Read more »
Source: manilabulletin - 🏆 25. / 51 Read more »